Cargando…
PLEKHH2 binds β-arrestin1 through its FERM domain, activates FAK/PI3K/AKT phosphorylation, and promotes the malignant phenotype of non-small cell lung cancer
PLEKHH2 is an important FERM domain containing-protein. However, the role of PLEKHH2 in human solid tumors has not been reported yet. We report that PLEKHH2 showed enhanced cytoplasmic expression in non-small cell lung cancer (NSCLC). Its overexpression was positively correlated with high TNM stage,...
Autores principales: | Wang, Rui, Wang, Si, Li, Zhen, Luo, Yuan, Zhao, Yue, Han, Qiang, Rong, Xue-Zhu, Guo, Yao-Xing, Liu, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547923/ https://www.ncbi.nlm.nih.gov/pubmed/36209201 http://dx.doi.org/10.1038/s41419-022-05307-5 |
Ejemplares similares
-
AGO2 involves the malignant phenotypes and FAK/PI3K/AKT signaling pathway in hypopharyngeal-derived FaDu cells
por: Zhang, Yanhui, et al.
Publicado: (2017) -
LRRK2 Inhibits FAK Activity by Promoting FERM-mediated Autoinhibition of FAK and Recruiting the Tyrosine Phosphatase, SHP-2
por: Choi, Insup, et al.
Publicado: (2016) -
Lasp1 promotes malignant phenotype of non-small-cell lung cancer via inducing phosphorylation of FAK-AKT pathway
por: Zhang, Xiupeng, et al.
Publicado: (2017) -
High resolution crystal structure of the FAK FERM domain reveals new insights on the Druggability of tyrosine 397 and the Src SH3 binding site
por: Marlowe, Timothy, et al.
Publicado: (2019) -
β-Arrestin-2 attenuates hepatic ischemia-reperfusion injury by activating PI3K/Akt signaling
por: Chen, Xiaolong, et al.
Publicado: (2020)